Designed to meet the needs of clinical laboratories by offering compliance to regulatory mandates, efficiency, ease of use, and run schedule flexibility, Thermo Fisher Scientific is introducing the Applied Biosystems SeqStudio Flex Dx Genetic Analyzer.
SeqStudio Flex Dx is an IVDR-compliant capillary electrophoresis (CE) system that supports both clinical as well as research for Sanger sequencing and fragment analysis in targeted genomic testing.
Clinical or hospital laboratories commonly struggle with time-sensitive demands, which include the need for accurate results, faster time-to-answer workflows, and the training required to use diagnostic instruments. Designed to help laboratories stay compliant amid this fast-paced environment, the SeqStudio Flex Dx offers flexible modes and features, allowing laboratories to streamline their workflows and spend more time focused on diagnostics.
The SeqStudio Flex Dx brings a deeper level of workflow integration and ease-of-use to Thermo Fisher’s trusted CE platform, delivering schedule flexibility, improved connectivity and data quality, and updated integration with regulated workflows.
